SHINE Fusion

SHINE is a leading provider of SPECT imaging radiopharmaceuticals, delivering dependable solutions for cardiac and neurological diagnostics. Their product range includes Tc-99m generators and specialized radiopharmaceutical kits designed for various applications, such as myocardial perfusion imaging and pulmonary function assessments. Clinicians rely on SHINE’s offerings to facilitate routine diagnostic scans that evaluate heart function, brain perfusion, and more, supporting effective patient management.

The company's commitment to reliable supply is backed by diversified sourcing of Molybdenum-99, ensuring consistent weekly deliveries and minimizing disruptions. SHINE’s comprehensive service includes ordering assistance and workflow support tailored to the needs of clinical teams. Notable products include the Tc-99m sestamibi kit for heart evaluation, the Tc-99m bicisate kit for stroke assessment, and inhaled radiopharmaceuticals for lung imaging. With a focus on safety and effective healthcare solutions, SHINE continues to foster enhanced clinical outcomes in nuclear medicine.